Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
तुलना करने के लिए मीट्रिक्स | CIPL | पीअर्स समकक्ष - बारीकी से मेल खाने वाली कंपनियों से संबंधित मेट्रिक्स का औसत CIPL: HIKAL, AUROPHARMA, MOREPENLAB, LUPIN, MANKIND | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधCIPLपीअर्सक्षेत्र |
---|---|---|---|---|
पी/ई अनुपात | 0.0x | 44.5x | −0.6x | |
PEG अनुपात | 0.00 | 0.30 | 0.00 | |
क़ीमत/बुक | 0.0x | 6.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 0.0x | 5.2x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 0.0% | 0.3% | 47.1% | |
उचित मूल्य अपसाइड | अनलॉक करें | −19.9% | 7.1% | अनलॉक करें |